Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

GM-CSF for Reversal of immunopAralysis in pediatriC sEpsis-induced MODS (GRACE)

NCT03769844 is registered in ClinicalTrials.gov with Nationwide Children's Hospital as lead sponsor.

NCT NCT03769844
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03769844 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
GM-CSF for Reversal of immunopAralysis in pediatriC sEpsis-induced MODS (GRACE)
Lead sponsor
Nationwide Children's Hospital
Phase
Phase 4
Overall status
Completed
Start date
December 5, 2018
Completion date
December 5, 2023
Enrollment
75 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

pediatric sepsis-induced mods